Company news

Share this article:
Wyeth Pharmaceuticals and Santaris Pharma have announced a strategic alliance to develop and commercialize RNA-based medicines. Under the terms of the agreement, Santaris will receive an upfront payment of $7 million in cash, and Wyeth will make a $10 million equity investment in Santaris. Additionally, Santaris may be entitled to further milestone payments of up to $83 million for each of 10 potential targets.
 
Abbott has announced the acquisition of Advanced Medical Optics for a total transaction value of approximately $2.8 billion. The deal represents an expansion of Abbott's medical device business, and will provide a long-term sustainable growth platform with more than $1 billion in annual sales, according to a company statement.
 
InVentiv Health has consolidated four of its existing New Jersey locations, and relocated its headquarters to a new space in Somerset, NJ. The location, set to open in July 2009, will house employees from two inVentiv offices in Somerset, and the offices of The Franklin Group and Strategyx, both of Somerville.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.